HomepageMedicineFDA Approves Vanda Pharmaceuticals' Fanapt to Treat Adults with Bipolar I Disorder Medicine FDA Approves Vanda Pharmaceuticals' Fanapt to Treat Adults with Bipolar I Disorder admin Posted on April 4, 2024 Fanapt was previously approved by the FDA in 2009 as an antipsychotic treatment for schizophrenia. LEAVE A RESPONSE Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment. admin View all posts Post navigation Previous PostTemu o optužbama njemačkih potrošačkih organizacija: “Naša praksa je poštena” Next PostHow a Violin Maker’s Dreams Came True in Cremona, Italy You Might Also Like Medicine Biotech in the Empire State: Building a World-Class Bioscience Ecosystem in New York admin January 4, 2025 Medicine Arcutis Biotherapeutics, Inc’s Zoryve Gets FDA Approval for Seborrheic Dermatitis admin January 1, 2024 Medicine Aspiring for the C-Suite? Consider Being a Chief of Staff admin April 12, 2024 Medicine FDA Approves Rybrevant for Locally Advanced, Metastatic Epidermal Growth Factor Receptor Mutated Non-Small Cell Lung Cancer admin September 21, 2024
Medicine Biotech in the Empire State: Building a World-Class Bioscience Ecosystem in New York admin January 4, 2025
Medicine Arcutis Biotherapeutics, Inc’s Zoryve Gets FDA Approval for Seborrheic Dermatitis admin January 1, 2024
Medicine FDA Approves Rybrevant for Locally Advanced, Metastatic Epidermal Growth Factor Receptor Mutated Non-Small Cell Lung Cancer admin September 21, 2024